Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 4 |
NetGPI | no | yes: 0, no: 4 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 4 |
GO:0110165 | cellular anatomical entity | 1 | 4 |
Related structures:
AlphaFold database: Q4Q637
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 116 | 118 | PF00675 | 0.492 |
CLV_NRD_NRD_1 | 52 | 54 | PF00675 | 0.424 |
CLV_PCSK_KEX2_1 | 116 | 118 | PF00082 | 0.492 |
CLV_PCSK_KEX2_1 | 47 | 49 | PF00082 | 0.432 |
CLV_PCSK_PC1ET2_1 | 47 | 49 | PF00082 | 0.432 |
CLV_PCSK_PC7_1 | 112 | 118 | PF00082 | 0.476 |
CLV_PCSK_SKI1_1 | 47 | 51 | PF00082 | 0.429 |
DOC_CKS1_1 | 68 | 73 | PF01111 | 0.678 |
DOC_CYCLIN_yCln2_LP_2 | 14 | 20 | PF00134 | 0.389 |
DOC_PP2B_LxvP_1 | 14 | 17 | PF13499 | 0.389 |
DOC_PP4_FxxP_1 | 22 | 25 | PF00568 | 0.373 |
DOC_USP7_MATH_1 | 108 | 112 | PF00917 | 0.785 |
DOC_WW_Pin1_4 | 67 | 72 | PF00397 | 0.678 |
DOC_WW_Pin1_4 | 92 | 97 | PF00397 | 0.743 |
LIG_14-3-3_CanoR_1 | 102 | 108 | PF00244 | 0.685 |
LIG_FHA_1 | 13 | 19 | PF00498 | 0.414 |
LIG_FHA_2 | 145 | 151 | PF00498 | 0.640 |
LIG_FHA_2 | 5 | 11 | PF00498 | 0.458 |
LIG_LIR_Gen_1 | 77 | 86 | PF02991 | 0.617 |
LIG_LIR_Nem_3 | 77 | 83 | PF02991 | 0.674 |
LIG_Pex14_2 | 22 | 26 | PF04695 | 0.360 |
LIG_SH2_CRK | 33 | 37 | PF00017 | 0.614 |
LIG_SH2_STAP1 | 45 | 49 | PF00017 | 0.630 |
LIG_SH2_STAT5 | 12 | 15 | PF00017 | 0.389 |
LIG_SH3_3 | 65 | 71 | PF00018 | 0.681 |
LIG_UBA3_1 | 49 | 55 | PF00899 | 0.566 |
MOD_CDC14_SPxK_1 | 99 | 102 | PF00782 | 0.760 |
MOD_CDK_SPK_2 | 67 | 72 | PF00069 | 0.678 |
MOD_CDK_SPxK_1 | 96 | 102 | PF00069 | 0.760 |
MOD_CDK_SPxxK_3 | 67 | 74 | PF00069 | 0.676 |
MOD_CK1_1 | 106 | 112 | PF00069 | 0.801 |
MOD_CK1_1 | 119 | 125 | PF00069 | 0.701 |
MOD_CK1_1 | 126 | 132 | PF00069 | 0.595 |
MOD_CK1_1 | 4 | 10 | PF00069 | 0.531 |
MOD_CK2_1 | 136 | 142 | PF00069 | 0.713 |
MOD_GlcNHglycan | 125 | 128 | PF01048 | 0.605 |
MOD_GSK3_1 | 106 | 113 | PF00069 | 0.796 |
MOD_GSK3_1 | 116 | 123 | PF00069 | 0.716 |
MOD_GSK3_1 | 136 | 143 | PF00069 | 0.712 |
MOD_GSK3_1 | 144 | 151 | PF00069 | 0.670 |
MOD_GSK3_1 | 92 | 99 | PF00069 | 0.782 |
MOD_N-GLC_1 | 103 | 108 | PF02516 | 0.536 |
MOD_N-GLC_1 | 123 | 128 | PF02516 | 0.403 |
MOD_PIKK_1 | 116 | 122 | PF00454 | 0.734 |
MOD_PKA_1 | 116 | 122 | PF00069 | 0.672 |
MOD_PKA_2 | 111 | 117 | PF00069 | 0.790 |
MOD_PKA_2 | 120 | 126 | PF00069 | 0.758 |
MOD_Plk_1 | 103 | 109 | PF00069 | 0.735 |
MOD_Plk_1 | 136 | 142 | PF00069 | 0.713 |
MOD_Plk_2-3 | 136 | 142 | PF00069 | 0.713 |
MOD_Plk_2-3 | 145 | 151 | PF00069 | 0.663 |
MOD_Plk_2-3 | 85 | 91 | PF00069 | 0.722 |
MOD_Plk_4 | 129 | 135 | PF00069 | 0.711 |
MOD_Plk_4 | 136 | 142 | PF00069 | 0.618 |
MOD_ProDKin_1 | 67 | 73 | PF00069 | 0.677 |
MOD_ProDKin_1 | 92 | 98 | PF00069 | 0.746 |
TRG_DiLeu_BaEn_2 | 45 | 51 | PF01217 | 0.566 |
TRG_ENDOCYTIC_2 | 33 | 36 | PF00928 | 0.616 |
TRG_ER_diArg_1 | 56 | 59 | PF00400 | 0.644 |
TRG_NLS_MonoExtC_3 | 52 | 57 | PF00514 | 0.614 |
TRG_NLS_MonoExtN_4 | 53 | 58 | PF00514 | 0.615 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3Q8IGB0 | Leishmania donovani | 87% | 100% |
A4I707 | Leishmania infantum | 87% | 100% |
E9B225 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 81% | 100% |